Abstracts

HIV Cure Research

Background: Two highly-publicized cures of HIV infection, one in an adult who received complex therapies for leukemia including myeloablative chemotherapy, total body irradiation, anti-thymocyte globulin and allogeneic hematopoietic stem cell transplantation from CCR5 delta 32 homozygous donor, and one in an infant started on ART within 2 days of birth, have inspired worldwide efforts to…

HIV PREVENTION RESEARCH: PROGRESS AND CHALLENGES

Background: HIV prevention trials have been conducted assessing a range of approaches to decrease the incidence of HIV infection, including vaccination, circumcision, vaginal and rectal microbicides, oral pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP). Of these, male circumcision, one vaccine combination, 1% tenofovir gel used at the time of sex, oral emtricitabine/tenofovir or tenofovir,…

Pathogenesis and Control of HCV Infection

Background: Hepatitis C virus (HCV)-related liver disease has emerged as one of the most important causes of morbidity and mortality in HIVinfected persons. Compared to persons with just one infection, HIV/HCV-coinfected persons have a higher incidence of all liver complications and eve some extrahepatic conditions raising the possibility of multiple pathogenic interactions. HCV can be…

Liver Management

Background: New agents for HCV treatment have dramatically improved both ease and success of treatment intervention. It is imperative that healthcare providers managing HCV understand key concepts in the staging of liver disease, and critical management considerations.Staging of liver disease to determine if advanced fibrosis or cirrhosis is present remains important. Cirrhosis is associated with…

Interactive Case Presentations

Background: The recent approval of more potent and better-tolerated therapies for HCV infection, including in those with HIV-1 co-infection, heralds the beginning of a new era in HCV therapeutics. Interferon-free therapy is the new standard of care for patients with genotype 2 or 3 HCV infection; while highly efficacious IFN-containing triple therapies with a shortened…